国际口腔医学杂志 ›› 2026, Vol. 53 ›› Issue (3): 433-440.doi: 10.7518/gjkq.2026104

• 综述 • 上一篇    

泛凋亡在口腔疾病中的研究进展

朱玄德(),陈冠辉()   

  1. 中山大学附属第七医院口腔科 深圳 518107
  • 收稿日期:2025-01-23 修回日期:2025-08-08 出版日期:2026-05-01 发布日期:2026-04-24
  • 通讯作者: 陈冠辉
  • 作者简介:朱玄德,硕士,Email:zhuxd25@mail2.sysu.edu.cn
  • 基金资助:
    国家自然科学基金(82303794)

Research progress of PANoptosis in oral diseases

Xuande Zhu(),Guanhui Chen()   

  1. Dept. of Stomatology, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China
  • Received:2025-01-23 Revised:2025-08-08 Online:2026-05-01 Published:2026-04-24
  • Contact: Guanhui Chen
  • Supported by:
    National Natural Science Foundation of China(82303794)

摘要:

细胞程序性死亡是维持宿主免疫和内环境稳态的一种重要机制,对于病原体和宿主间的平衡至关重要。泛凋亡是近年来新提出的一种细胞死亡方式,主要由泛凋亡复合体调控,同时具有凋亡、焦亡、坏死性凋亡的特征。目前越来越多的研究聚焦于泛凋亡参与口腔疾病的机制,本文将泛凋亡的定义、特征、调控机制及其与口腔疾病的潜在关系作一综述,旨在为口腔疾病的检测、预防和治疗提供可能的解决思路。

关键词: 程序性细胞死亡, 泛凋亡, 泛凋亡复合体, 口腔疾病

Abstract:

Programmed cell death (PCD) serves as a crucial mechanism for maintaining host innate immunity, homeostasis, and the balance between pathogens and the host. PANoptosis is a novel form of programmed cell death that is primarily regulated by the PANoptosome complex and concurrently exhibits the features of apoptosis, pyroptosis, and necroptosis. Oral diseases, which significantly impact the quality of life and general health of patients, are a major concern. Interest in the underlying mechanisms of PANoptosis involved in oral diseases is currently increasing. This review explains the definition, characteristics, regulatory mechanisms of PANoptosis and its potential relationship with oral di-seases, aiming to offer possible solutions for the detection, prevention, and treatment of oral diseases.

Key words: programmed cell death, PANoptosis, PANoptosome, oral disease

中图分类号: 

  • R780.2

图1

泛凋亡的分子调控机制不同的刺激物能诱导泛凋亡复合体的组装,进而诱导泛凋亡的发生。IAV:influenza A virus,甲型流感病毒;C. albicans:Candida albicans,白色念珠菌;A. fumigatus:Aspergillus fumigatus,烟曲霉;HSV-1:herpes simplex virus type 1,单纯疱疹病毒1;F. novicida:Francisella novicida,新弗朗西丝菌;Yersinia:耶尔森菌;Heme:血红素;PAMPs:pathogen-associated molecular patterns,病原相关分子模式;TLR:Toll-like receptor,Toll样受体;TAK1:transforming growth factor-β-activated kinase 1,转化生长因子β活化激酶1;ADAR1:adenosine deaminase acting on RNA 1,作用于RNA 1的腺苷脱氨酶;CASP:caspase(Created with BioGDP.com)。"

[1] Newton K, Strasser A, Kayagaki N, et al. Cell death[J]. Cell, 2024, 187(2): 235-256.
[2] Subbarao Malireddi RK, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis) [J]. Front Cell Infect Microbiol, 2019, 9: 406.
[3] Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018[J]. Cell Death Differ, 2018, 25(3): 486-541.
[4] Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases[J]. Cell Death Differ, 2021, 28(7): 2029-2044.
[5] Liu X, Xia SY, Zhang ZB, et al. Channelling inflammation: gasdermins in physiology and disease[J]. Nat Rev Drug Discov, 2021, 20(5): 384-405.
[6] Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious di-seases[J]. Immunol Rev, 2017, 277(1): 61-75.
[7] Laurien L, Nagata M, Schünke H, et al. Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation[J]. Nat Commun, 2020, 11(1): 1747.
[8] Samson AL, Zhang Y, Geoghegan ND, et al. MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis[J]. Nat Commun, 2020, 11: 3151.
[9] Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy[J]. Pharmacol Ther, 2022, 232: 108010.
[10] Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)[J]. Immunol Rev, 2020, 297(1): 26-38.
[11] Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans [J]. Virulence, 2022, 13(1): 89-121.
[12] Place DE, Lee S, Kanneganti TD. PANoptosis in microbial infection[J]. Curr Opin Microbiol, 2021, 59: 42-49.
[13] Chen XT, Dai YF, Li YS, et al. Identification of cross-talk pathways and PANoptosis-related genes in periodontitis and Alzheimer’s disease by bioinformatics analysis and machine learning[J]. Front Aging Neurosci, 2024, 16: 1430290.
[14] Christgen S, Zheng M, Kesavardhana S, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis) [J]. Front Cell Infect Microbiol, 2020, 10: 237.
[15] Jiang S, Li H, Zhang L, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics[J]. Nucleic Acids Res, 2025, 53(d1): D1670-D1676.
[16] Kuriakose T, Kanneganti TD. ZBP1: innate sensor regulating cell death and inflammation[J]. Trends Immunol, 2018, 39(2): 123-134.
[17] Kesavardhana S, Subbarao Malireddi RK, Burton AR, et al. The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development[J]. J Biol Chem, 2020, 295(24): 8325-8330.
[18] Banoth B, Tuladhar S, Karki R, et al. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)[J]. J Biol Chem, 2020, 295(52): 18276-18283.
[19] Zheng M, Karki R, Vogel P, et al. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense[J]. Cell, 2020, 181(3): 674-687.e13.
[20] Karki R, Lee S, Mall R, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection[J]. Sci Immunol, 2022, 7(74): eabo6294.
[21] Lee S, Karki R, Wang YQ, et al. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence[J]. Nature, 2021, 597(7876): 415-419.
[22] Cuny GD, Degterev A. RIPK protein kinase family: atypical lives of typical kinases[J]. Semin Cell Dev Biol, 2021, 109: 96-105.
[23] Subbarao Malireddi RK, Kesavardhana S, Karki R, et al. RIPK1 distinctly regulates Yersinia-induced inflammatory cell death, PANoptosis[J]. Immunohorizons, 2020, 4(12): 789-796.
[24] Dillon CP, Weinlich R, Rodriguez DA, et al. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3[J]. Cell, 2014, 157(5): 1189-1202.
[25] Dannappel M, Vlantis K, Kumari S, et al. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis[J]. Nature, 2014, 513(7516): 90-94.
[26] Jin L, Chen J, Liu XY, et al. The double life of RIPK1[J]. Mol Cell Oncol, 2016, 3(1): e1035690.
[27] Geng JF, Ito Y, Shi LY, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis[J]. Nat Commun, 2017, 8(1): 359.
[28] Subbarao Malireddi RK, Gurung P, Kesavardhana S, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease[J]. J Exp Med, 2020, 217(3): jem.20191644.
[29] Sundaram B, Pandian N, Mall R, et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs[J]. Cell, 2023, 186(13): 2783-2801.e20.
[30] Henkel FDR, O’Neill LAJ. NLRP12 drives PANoptosis in response to heme[J]. Trends Immunol, 2023, 44(8): 574-576.
[31] Zhang AP, Zhang CC, Zhang YH, et al. PANoptosis is a compound death in periodontitis: a systematic review of ex vivo and in vivo studies[J]. Oral Dis, 2024, 30(4): 1828-1842.
[32] Aral K, Aral CA, Kapila Y. The role of caspase-8, caspase-9, and apoptosis inducing factor in perio-dontal disease[J]. J Periodontol, 2019, 90(3): 288-294.
[33] Shi J, Li J, Su W, et al. Loss of periodontal ligament fibroblasts by RIPK3-MLKL-mediated necroptosis in the progress of chronic periodontitis[J]. Sci Rep, 2019, 9(1): 2902.
[34] Bugueno IM, Batool F, Korah L, et al. Porphyromonas gingivalis differentially modulates apoptosome apoptotic peptidase activating factor 1 in epithelial cells and fibroblasts[J]. Am J Pathol, 2018, 188(2): 404-416.
[35] Li YY, Cai Q, Li BS, et al. The effect of Porphyromonas gingivalis lipopolysaccharide on the pyroptosis of gingival fibroblasts[J]. Inflammation, 2021, 44(3): 846-858.
[36] Chen Q, Liu XG, Wang DY, et al. Periodontal inflammation-triggered by periodontal ligament stem cell pyroptosis exacerbates periodontitis[J]. Front Cell Dev Biol, 2021, 9: 663037.
[37] Duan Y, An W, Wu YX, et al. Tetramethylpyrazine reduces inflammation levels and the apoptosis of LPS-stimulated human periodontal ligament cells via the downregulation of miR-302b[J]. Int J Mol Med, 2020, 45(6): 1918-1926.
[38] Oka S, Li XY, Sato F, et al. A deficiency of Dec2 triggers periodontal inflammation and pyroptosis[J]. J Periodontal Res, 2021, 56(3): 492-500.
[39] Sun DD, Wu X, Lin SC, et al. Anti-apoptosis and anti-inflammation activity of circ_0097010 downregulation in lipopolysaccharide-stimulated periodontal ligament cells by miR-769-5p/Krüppel like factor 6 axis[J]. J Dent Sci, 2023, 18(1): 310-321.
[40] Yang YN, Wang LX, Zhang HB, et al. Mixed lineage kinase domain-like pseudokinase-mediated necroptosis aggravates periodontitis progression[J]. J Mol Med (Berl), 2022, 100(1): 77-86.
[41] Ke XJ, Lei L, Li H, et al. Manipulation of necroptosis by Porphyromonas gingivalis in periodontitis development[J]. Mol Immunol, 2016, 77: 8-13.
[42] Li J, Shi JH, Pan Y, et al. Transcription modulation by CDK9 regulates inflammatory genes and RIPK3-MLKL-mediated necroptosis in periodontitis progression[J]. Sci Rep, 2019, 9(1): 17369.
[43] Zhang KY, Chen XX, Zhou R, et al. Inhibition of gingival fibroblast necroptosis mediated by RIPK3/MLKL attenuates periodontitis[J]. J Clin Periodontol, 2023, 50(9): 1264-1279.
[44] Jiang WY, Deng ZL, Dai XZ, et al. PANoptosis: a new insight into oral infectious diseases[J]. Front Immunol, 2021, 12: 789610.
[45] Tomalka J, Ganesan S, Azodi E, et al. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans [J]. PLoS Pathog, 2011, 7(12): e1002379.
[46] Cao MT, Wu ZX, Lou Q, et al. Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection[J]. Cell Death Differ, 2019, 26(12): 2622-2636.
[47] Wang X, Li Y, Liu S, et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense[J]. Proc Natl Acad Sci U S A, 2014, 111(43): 15438-15443.
[48] Yu XL, Li Y, Chen Q, et al. Herpes simplex virus 1 (HSV-1) and HSV-2 mediate species-specific modulations of programmed necrosis through the viral ribonucleotide reductase large subunit R1[J]. J Virol, 2015, 90(2): 1088-1095.
[49] Guo HY, Omoto S, Harris PA, et al. Herpes simplex virus suppresses necroptosis in human cells[J]. Cell Host Microbe, 2015, 17(2): 243-251.
[50] Siqueira JF Jr, Rôças IN. Present status and future directions: microbiology of endodontic infections[J]. Int Endod J, 2022, 55(): 512-530.
[51] Liu L, Liang LP, Yang CH, et al. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway[J]. Gut Microbes, 2021, 13(1): 1-20.
[52] Liu H, Liu YX, Fan W, et al. Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis[J]. Cell Commun Signal, 2022, 20(1): 196.
[53] Ran S, Chu M, Gu S, et al. Enterococcus faecalis induces apoptosis and pyroptosis of human osteoblastic MG63 cells via the NLRP3 inflammasome[J]. Int Endod J, 2019, 52(1): 44-53.
[54] Dai X, Deng Z, Liang Y, et al. Enterococcus faecalis induces necroptosis in human osteoblastic MG63 cells through the RIPK3/MLKL signalling pathway[J]. Int Endod J, 2020, 53(9): 1204-1215.
[55] Chi DL, Lin XW, Meng QZ, et al. Real-time induction of macrophage apoptosis, pyroptosis, and necro-ptosis by Enterococcus faecalis OG1RF and two root canal isolated strains[J]. Front Cell Infect Microbiol, 2021, 11: 720147.
[56] Mall R, Bynigeri RR, Karki R, et al. Pancancer transcriptomic profiling identifies key PANoptosis mar-kers as therapeutic targets for oncology[J]. NAR Cancer, 2022, 4(4): zcac033.
[57] Karki R, Sundaram B, Sharma BR, et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis[J]. Cell Rep, 2021, 37(3): 109858.
[58] Subbarao Malireddi RK, Karki R, Sundaram B, et al. Inflammatory cell death, PANoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth[J]. Immunohorizons, 2021, 5(7): 568-580.
[59] Yang P, Huang GZ, Li YL, et al. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma[J]. Sci Rep, 2024, 14(1): 9824.
[60] Gao F, Zhang MH, Ying ZG, et al. A PANoptosis pattern to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma[J]. Heliyon, 2024, 10(5): e27162.
[61] Jiang XY, Fu TT, Huang L. PANoptosis: a new insight for oral diseases[J]. Mol Biol Rep, 2024, 51(1): 960.
[1] 伍行,刘玉平,张伊钒,夏郁葱,李照禾,易小炜,夏鸿,丁文文. 原花青素对口腔疾病调控机制和防治的研究进展[J]. 国际口腔医学杂志, 2025, 52(5): 644-654.
[2] 赵南洋,吴娟娟,周洲,陈欣月,张旭彤,徐逸飞,戴泰鸣. 贵州省实施儿童口腔疾病综合干预项目地区与非干预地区12岁儿童口腔健康状况调查分析[J]. 国际口腔医学杂志, 2025, 52(4): 484-489.
[3] 黄启航,王航,王耀钟,李德超. 静电纺丝纳米纤维在颌面部组织修复中的应用[J]. 国际口腔医学杂志, 2025, 52(4): 526-533.
[4] 毛鸿晨,王铮,杨德琴. 牙龈卟啉单胞菌外膜囊泡在口腔疾病中的作用及其机制的研究进展[J]. 国际口腔医学杂志, 2024, 51(5): 608-615.
[5] 傅豫, 何薇, 黄兰. 铁死亡在口腔疾病中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 36-44.
[6] 杨倩娟,宋致馨,方世殊,顾泽旭,金作林,刘倩. 基于唾液代谢组学的口腔疾病研究新进展[J]. 国际口腔医学杂志, 2023, 50(3): 321-328.
[7] 陈艺菲,张滨婧,冯淑琦,徐锐,杨淑娴,李雨庆. 黄酮类化合物对口腔微生物的影响及其机制[J]. 国际口腔医学杂志, 2023, 50(2): 210-216.
[8] 刘千溪,吴佳益,任彪,黄睿洁. 粪肠球菌与口腔微生物相互作用的研究进展[J]. 国际口腔医学杂志, 2022, 49(3): 290-295.
[9] 陈静,葛子瑜,俞婷婷,章燕珍. 帕金森病与口腔疾病相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 218-224.
[10] 易祖木,王昕宇,伍颖颖. 糖尿病患者口腔细菌多样性的变化[J]. 国际口腔医学杂志, 2020, 47(5): 522-529.
[11] 胡垚,程磊,郭强,任彪. 白假丝酵母与口腔常见细菌相互作用的进展研究[J]. 国际口腔医学杂志, 2019, 46(6): 663-669.
[12] 姜雪,黄淡远,廖文. 磷酸钛氧钾激光应用于口腔疾病治疗的研究进展[J]. 国际口腔医学杂志, 2019, 46(4): 456-462.
[13] 李伟,周京琳. 口腔代谢组学研究[J]. 国际口腔医学杂志, 2019, 46(3): 249-252.
[14] 吴东蕾,刘静. 氧化应激损伤与口腔疾病相关性的研究进展[J]. 国际口腔医学杂志, 2019, 46(1): 62-67.
[15] 陶艳,周瑜,陈谦明. 维生素B12缺乏口腔表征的研究进展[J]. 国际口腔医学杂志, 2019, 46(1): 78-83.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!